U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Alendronate

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Year introduced: 1997 (1987)

PubMed search builder options

Subheadings:

Tree Number(s): D02.705.429.500.100

MeSH Unique ID: D019386

Registry Number: X1J18R4W8P

Entry Terms:

  • Aminohydroxybutane Bisphosphonate
  • 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
  • MK-217
  • MK217
  • MK 217
  • Fosamax
  • Alendronate Sodium
  • Alendronate Monosodium Salt, Trihydrate

Previous Indexing:

Pharmacologic Action:

Supplemental Content

Loading ...